Robinson, RichardMarconi, LorenzoMacPepple, EkelechiHakenberg, Oliver W.Watkin, NickYuan, YuhongLam, ThomasMacLennan, StevenAdewuyi, Temitope E.Coscione, AlbertoMinhas, Suks S.Compérat, Eva M.Necchi, Andrea2019-04-232019-04-232018-07Robinson, R, Marconi, L, MacPepple, E, Hakenberg, O W, Watkin, N, Yuan, Y, Lam, T, MacLennan, S, Adewuyi, T E, Coscione, A, Minhas, S S, Compérat, E M & Necchi, A 2018, 'Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer : A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel', European Urology, vol. 74, no. 1, pp. 76-83. https://doi.org/10.1016/j.eururo.2018.04.0030302-2838ORCID: /0000-0002-2691-8421/work/61024721http://hdl.handle.net/2164/12211Richard Robinson certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: Dr. Thomas Lam is a company consultant for and has received company speaker honoraria from Pfizer, GSK, Astellas, and Ipsen. Mr. Suks S. Minhas receives company speaker honorarium for Lilly and has received a fellowship/medical travel grant from American Medical systems Fellowship. Dr. Andrea Necchi is a company consultant for and has received company speaker honoraria from Bayer and Astra Zeneca, and has received a fellowship/medical travel grant from Pierre Fabre; he has been involved with trial participation for Roche, Merck Sharp & Dohme, BMS, and Novartis, as well as receiving grants/research supports from GlaxoSmithKline and Millenium. Oliver Hakenberg, Nick Watkin, Richard Robinson, Yuhong Yuan, Ekelechi MacPepple, Temitope E. Adewuyi, Steven MacLennan, Alberto Coscione, and Eva M. Compérat have nothing to declare.8348636engSDG 3 - Good Health and Well-beingpenile canceradjuvant radiotherapylymph nodesR Medicine (General)R1Journal article10.1016/j.eururo.2018.04.003741